{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:20:32Z","timestamp":1792246832416,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1194694"],"award-info":[{"award-number":["GNT1194694"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2017498"],"award-info":[{"award-number":["2017498"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012789","name":"Veski","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018675","name":"Kids' Cancer Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018675","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022890","name":"Maddie Riewoldt's Vision","doi-asserted-by":"publisher","award":["MRV0027"],"award-info":[{"award-number":["MRV0027"]}],"id":[{"id":"10.13039\/501100022890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jtct.2025.01.894","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T11:43:14Z","timestamp":1738755794000},"page":"321.e1-321.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Co-designing a Novel Ordinal Endpoint for an Adaptive Platform Trial, BANDICOOT, in Pediatric Hematopoietic Stem Cell Transplant"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3851-7502","authenticated-orcid":false,"given":"Hannah","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2119-3844","authenticated-orcid":false,"given":"Lorna","family":"McLeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Meyran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2845-2304","authenticated-orcid":false,"given":"Li-yin","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7211-1891","authenticated-orcid":false,"given":"Peter","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Stolper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5476-9323","authenticated-orcid":false,"given":"Stacie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Dyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori Chait","family":"Rubinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6808-1658","authenticated-orcid":false,"given":"Kaitlyn","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1277-5538","authenticated-orcid":false,"given":"Chris J.","family":"Selman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"Grobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8334-0291","authenticated-orcid":false,"given":"Katherine J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Snelling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8272-4074","authenticated-orcid":false,"given":"Theresa","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Gwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2344-1365","authenticated-orcid":false,"given":"Rachel","family":"Conyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2025.01.894_bib0001","unstructured":"Australia and New Zealand Transplant and Cellular Therapies, ANZTCT Registry: Annual Data Summary 2022. (2022)."},{"issue":"7","key":"10.1016\/j.jtct.2025.01.894_bib0002","doi-asserted-by":"crossref","first-page":"409.e1","DOI":"10.1016\/j.jtct.2022.04.012","article-title":"Updated trends in hematopoietic cell transplantation in the United States with an additional focus on adolescent and young adult transplantation activity and outcomes","volume":"28","author":"Phelan","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.01.894_bib0003","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fped.2019.00381","article-title":"Inborn Errors Working Party of the European Society for, B. & Marrow, T. Long Term Outcome and Immune Function After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency","volume":"7","author":"Gennery","year":"2019","journal-title":"Front Pediatr"},{"issue":"12","key":"10.1016\/j.jtct.2025.01.894_bib0004","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.bbmt.2015.08.023","article-title":"Transplant outcomes for children with T cell acute lymphoblastic leukemia in second remission: a report from the Center for International Blood and Marrow Transplant Research","volume":"21","author":"Burke","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2025.01.894_bib0005","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jtct.2022.06.005","article-title":"Hematopoietic cell transplantation in the treatment of pediatric acute myelogenous leukemia and myelodysplastic syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy","volume":"28","author":"Tarlock","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.01.894_bib0006","doi-asserted-by":"crossref","first-page":"1161573","DOI":"10.3389\/fonc.2023.1161573","article-title":"Prognostic factors and predictive scores for 6-month mortality of hematopoietic stem cell transplantation recipients admitted to the pediatric intensive care unit","volume":"13","author":"Schober","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtct.2025.01.894_bib0007","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1182\/bloodadvances.2020003418","article-title":"How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT","volume":"4","author":"Penack","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2025.01.894_bib0008","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12885-021-07897-3","article-title":"Early transplantation-related mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia","volume":"21","author":"Kong","year":"2021","journal-title":"BMC Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.jtct.2025.01.894_bib0009","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/bmt.2012.282","article-title":"Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation","volume":"48","author":"Iacobelli","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.01.894_bib0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2022.23257","article-title":"Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial","volume":"329","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2025.01.894_bib0011","unstructured":"U.S. Food and Drug Administration. Adaptive Designs for Clinical Trials of Drugs and Biologics: Guidance for Industry. November 2019. Accessible: https:\/\/www.fda.gov\/media\/78495\/download"},{"key":"10.1016\/j.jtct.2025.01.894_bib0012","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13063-023-07262-8","article-title":"Statistical analyses of ordinal outcomes in randomised controlled trials: protocol for a scoping review","volume":"24","author":"Selman","year":"2023","journal-title":"Trials"},{"key":"10.1016\/j.jtct.2025.01.894_bib0013","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.bmt.1704316","article-title":"Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know","volume":"33","author":"Leather","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.01.894_bib0014","unstructured":"UK Stem Cell Strategic Forum. A 10 Year Vision for Stem Cell Transplantation and Cellular Therapies. NHS Blood and Transplant; 2022. Available at: https:\/\/www.nhsbt.nhs.uk\/who-we-are\/performance-and-strategy\/stem-cell-and-advanced-cellular-therapy-strategy\/"},{"key":"10.1016\/j.jtct.2025.01.894_bib0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13023-020-1293-0","article-title":"Cross-cutting view of current challenges in paediatric solid organ and haematopoietic stem cell transplantation in Europe: the European Reference Network TransplantChild","volume":"15","author":"Jara","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtct.2025.01.894_bib0016","first-page":"e60034","article-title":"Pediatric sequential organ assessment score: a comprehensive review of the prognostic marker in the pediatric intensive care unit","volume":"16","author":"Malik","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jtct.2025.01.894_bib0017","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)13908-6","article-title":"Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study","volume":"362","author":"Leteurtre","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2025.01.894_bib0018","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.kint.2023.07.013","article-title":"Using causal directed acyclic graphs (DAGs) to select patient-important outcomes in transplantation trials\u2013interventions to treat polyomavirus infection as an example","volume":"104","author":"Wu","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.jtct.2025.01.894_bib0019","doi-asserted-by":"crossref","first-page":"10136","DOI":"10.3389\/ti.2022.10136","article-title":"Surrogate endpoints for late kidney transplantation failure","volume":"35","author":"Naesens","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.jtct.2025.01.894_bib0020","series-title":"R: A Language and Environment for Statistical Computing","year":"2024"},{"key":"10.1016\/j.jtct.2025.01.894_bib0021","article-title":"Biomarkers to predict and diagnose pulmonary complications in children post haematopoietic stem cell transplant","volume":"13","author":"Walker","year":"2024","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.jtct.2025.01.894_bib0022","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.2020007905","article-title":"CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation","volume":"137","author":"de Koning","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.01.894_bib0023","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jcyt.2020.05.005","article-title":"Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation","volume":"22","author":"van Roessel","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jtct.2025.01.894_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcped.2023.100131","article-title":"Virus infections after allogeneic stem cell transplantation in children. Review","volume":"2","author":"Rauwolf","year":"2023","journal-title":"EJC Paediatric Oncology"},{"key":"10.1016\/j.jtct.2025.01.894_bib0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13063-024-08072-2","article-title":"Statistical analyses of ordinal outcomes in randomised controlled trials: a scoping review","volume":"25","author":"Selman","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.jtct.2025.01.894_bib0026","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jtct.2021.05.005","article-title":"Novel composite endpoints after allogeneic hematopoietic cell transplantation","volume":"27","author":"Kim","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.01.894_bib0027","unstructured":"Department of Health and Aged Care. Principles for Consumer Involvement in Research Funded by the Medical Research Future Fund. Canberra: Australian Government; 2023. Accessible: https:\/\/www.health.gov.au\/resources\/publications\/principles-for-consumer-involvement-in-research-funded-by-the-medical-research-future-fund?language=en"},{"key":"10.1016\/j.jtct.2025.01.894_bib0028","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/sim.6581","article-title":"Use of composite endpoints in clinical trials","volume":"35","author":"Sankoh","year":"2016","journal-title":"Stat Med"},{"key":"10.1016\/j.jtct.2025.01.894_bib0029","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2352-3026(15)00045-9","article-title":"Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2025.01.894_bib0030","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fcimb.2020.00202","article-title":"The CD4+ T cell response to human cytomegalovirus in healthy and immunocompromised people","volume":"10","author":"Lim","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jtct.2025.01.894_bib0031","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood-2018-03-840702","article-title":"SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery","volume":"132","author":"Haddad","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.01.894_bib0032","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bbmt.2018.10.011","article-title":"Cytomegalovirus infection incidence and risk factors across diverse hematopoietic cell transplantation platforms using a standardized monitoring and treatment approach: a comprehensive evaluation from a single institution","volume":"25","author":"Melendez-Munoz","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.01.894_bib0033","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/infdis\/jiad386","article-title":"Cytomegalovirus viral load threshold to guide preemptive therapy in hematopoietic cell transplant recipients: correlation with cytomegalovirus disease","volume":"229","author":"Sadowska-Klasa","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jtct.2025.01.894_bib0034","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jtct.2021.09.010","article-title":"American Society for Transplantation and Cellular Therapy Series: #4 \u2014 Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation","volume":"27","author":"Yong","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.01.894_bib0035","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cid\/cit358","article-title":"Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study","volume":"57","author":"Ogata","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2025.01.894_bib0036","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.bmt.1705907","article-title":"Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation","volume":"41","author":"Ogata","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.01.894_bib0037","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1399-3046.2007.00851.x","article-title":"High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy","volume":"12","author":"Anderson","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2025.01.894_bib0038","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2141.2011.08855.x","article-title":"Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation","volume":"155","author":"Worth","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2025.01.894_bib0039","doi-asserted-by":"crossref","first-page":"e2108","DOI":"10.1002\/rmv.2108","article-title":"Epstein-Barr virus related post-transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Lindsay","year":"2020","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jtct.2025.01.894_bib0040","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1182\/bloodadvances.2023011002","article-title":"Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients","volume":"8","author":"Zinter","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2025.01.894_bib0041","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29549","article-title":"Survival of pediatric patients requiring admission in the intensive care unit post hematopoietic stem cell transplantation: Prognostic factors associated with mortality","volume":"69","author":"Zaidman","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2025.01.894_bib0042","article-title":"Pulmonary complications post allogeneic haematopoietic stem cell transplant in children","volume":"13","author":"Walker","year":"2024","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.jtct.2025.01.894_bib0043","doi-asserted-by":"crossref","first-page":"1385153","DOI":"10.3389\/fped.2024.1385153","article-title":"Risk factors predicting need for the pediatric intensive care unit (PICU) post-hematopoietic cell transplant, PICU utilization, and outcomes following HCT: a single center retrospective analysis","volume":"12","author":"Johnson","year":"2024","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jtct.2025.01.894_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.632263","article-title":"Continuous renal replacement therapy: a review of use and application in pediatric hematopoietic stem cell transplant recipients","volume":"11","author":"Elbahlawan","year":"2021","journal-title":"Front Oncol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725010073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725010073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:00:32Z","timestamp":1778922032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725010073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2666636725010073"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.01.894","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-designing a Novel Ordinal Endpoint for an Adaptive Platform Trial, BANDICOOT, in Pediatric Hematopoietic Stem Cell Transplant","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.01.894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}